Trial Information

Summary: Postpartum anemia or anemia from heavy uterine bleeding

Ridgeview Research is conducting a clinical research study for women who have anemia from post partum or heavy uterine bleeding. This study will evaluate the efficacy, tolerability, and safety of an investigational IV drug when compared to standard medical care. Study visits will be at no cost to you.

Study Length/Visits: 5-6 weeks, up to 3 visits

Patient Inclusion Criteria:

• Women 18 years of age or older
• Heavy uterine bleeding within the past 6 months

Patient Exclusion Criteria:

• Treatment of asthma
• Active infection requiring antibiotics
• History of cancer

If you would like to learn more about participating in this study, please send an e-mail message using the form below.